Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study--authors' response
J Antimicrob Chemother
.
2015 Jan;70(1):321-2.
doi: 10.1093/jac/dku373.
Epub 2014 Sep 22.
Authors
Julie B Prahl
1
,
Isik S Johansen
2
,
Arieh S Cohen
3
,
Niels Frimodt-Møller
4
,
Åse B Andersen
5
Affiliations
1
International Reference Laboratory of Mycobacteriology, Statens Serum Institut, 5 Artillerivej, 2300 Copenhagen, Denmark jpl@ssi.dk.
2
Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
3
Department of Biochemistry, Immunology and Genetics, Statens Serum Institut, 5 Artillerivej, 2300 Copenhagen, Denmark.
4
Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Kettegård Alle 30, 2650 Hvidovre, Denmark.
5
Department of Infectious Diseases, Copenhagen University Hospital Rigshospitalet, 9 Blegdamsvej, 2100 Copenhagen Ø, Denmark.
PMID:
25246439
DOI:
10.1093/jac/dku373
No abstract available
Keywords:
anti-tuberculosis drugs; therapeutic drug monitoring; tuberculosis.
Publication types
Letter
Comment
MeSH terms
Antitubercular Agents / administration & dosage*
Antitubercular Agents / pharmacokinetics*
Female
Humans
Male
Tuberculosis / drug therapy*
Substances
Antitubercular Agents